Skip to content

Effect of intravenous Acetaminophen for abdominal pain management in patients with acute abdomen

Comparison of intravenous Acetaminophen and Morphine sulfate for abdominal pain management in patients with acute abdomen

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017110427097N5
Enrollment
120
Registered
2017-11-17
Start date
2017-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute abdomen. Acute abdomen

Interventions

Intervention 1: Intervention group (1): Acetaminophen, 15 mg/kg/100cc normal saline, intravenous infusion, for 30 minutes. Intervention 2: Intervention group (2): morphine sulfate, 0.1 mg/kg, intraven
Treatment - Drugs
Intervention group (1): Acetaminophen, 15 mg/kg/100cc normal saline, intravenous infusion, for 30 minutes
Intervention group (2): morphine sulfate, 0.1 mg/kg, intravenous injection, for 1.5 to 2 minutes

Sponsors

Vice Chancellor for research of Ardebil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients above 18 years; stable vital signs; acute abdominal pain. Exclusion criteria: Patients with a history of hypersensitivity to morphine or other opioids; proven or probable pregnancy; breastfeeding; drug addiction; get an analgesic drugs since six hours before admission to the emergency department.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain control. Timepoint: Before the intervention, 30 minuts after the intervention. Method of measurement: Visual Analog Scale.

Secondary

MeasureTime frame
Side Effects. Timepoint: Before the intervention, 30 minuts after the intervention. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mosanen Tabatabaii

Ardebil University of Medical Sciences

Tabatabaii_MM70@yahoo.com+45 33 51 20 06

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026